Australia markets closed

Lantern Pharma Inc. (LTRN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.6900-0.2200 (-4.48%)
At close: 04:00PM EDT
4.6608 -0.03 (-0.62%)
Pre-market: 08:00AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-17,535
-15,962
-14,260
-12,363
-5,908
-
Depreciation & amortisation
15.258
14.615
10.081
6.761
3.388
-
Stock-based compensation
868.042
1,068
1,188
961.545
1,192
-
Change in working capital
2,909
538.024
-611.863
599.957
-939.06
-
Other working capital
-13,670
-14,365
-12,795
-10,607
-5,668
-
Other non-cash items
161.287
160.228
144.6
90.66
-
-
Net cash provided by operating activities
-13,658
-14,347
-12,767
-10,592
-5,652
-
Cash flows from investing activities
Investments in property, plant and equipment
-12.075
-18.734
-27.844
-15.499
-16.137
-
Purchases of investments
-11,106
-8,196
-3,913
-19,579
0
-
Sales/maturities of investments
10,593
7,285
4,120
64.093
0
-
Net cash used for investing activities
-525.501
-930.21
179.268
-19,531
-16.137
-
Cash flows from financing activities
Debt repayment
-
-
-
0
-169.049
0
Common stock issued
-
-
0
69,000
26,250
-
Common stock repurchased
-
-499.997
-2,482
-939.666
-
-
Other financing activities
-
-
-
-4,784
-2,746
-
Net cash used provided by (used for) financing activities
-445.281
-499.997
-2,182
63,416
23,665
-
Net change in cash
-14,662
-15,805
-14,781
33,295
17,997
-
Cash at beginning of period
33,020
37,743
52,524
19,229
1,232
-
Cash at end of period
18,391
21,938
37,743
52,524
19,229
-
Free cash flow
Operating cash flow
-13,658
-14,347
-12,767
-10,592
-5,652
-
Capital expenditure
-12.075
-18.734
-27.844
-15.499
-16.137
-
Free cash flow
-13,670
-14,365
-12,795
-10,607
-5,668
-